Intel’s $20 billion stock sale has surprising upside | Louis Velazquez - Official Website, Entrepreneur, Finance, Technology

Intel (INTC) priced a $20 billion stock offering this week, one of the largest equity raises in the history of the chip industry.

Shares fell nearly 4% when the deal was first announced, the kind of sell-off dilution almost always produces, according to CNBC. But at Bank of America, longtime semiconductor analyst Vivek Arya told clients the sell-off missed the real story.

Intel initially planned to raise $15 billion on Monday, Aug. 10, but demand pushed the deal higher overnight. The offering was upsized to $20 billion, with investors submitting more than $100 billion in orders, according to Bloomberg.

That level of demand for a stock already up 175% in 2026 signals confidence a one-day sell-off doesn’t capture.

The final price came in at $95 per share, a 6.5% discount to the Friday, Aug. 7, closing price, Bloomberg reported. Intel expects net proceeds of roughly $19.7 billion once the deal closes on Aug. 12, according to the company’s press release. JPMorgan, Goldman Sachs, Morgan Stanley, and Citigroup managed the offering.

Why BofA reads dilution as a bullish signal

BofA estimates the new shares will cut Intel’s earnings per share by 4% to 5% once the higher count flows into 2026 estimates, according to a Bank of America research note shared with me this week.

That cost is real. But Arya wrote that the raise looks less like a defensive balance sheet repair and more like a company funding growth it already expects to land.

The timing supports that read. Intel raised its 2026 capital spending forecast to more than $20 billion in July, up from an earlier range of $17 billion to $18 billion, Chief Financial Officer Dave Zinsner told CNBC, adding that Intel is bracing for a “meaningful increase” in spending again in 2027 as customer demand builds.

BofA’s note ties the new equity directly to that spending trajectory, along with continued progress on Intel’s next generation 14A manufacturing process.

The foundry math behind BofA’s price target

BofA’s price target cut, to $145 from $160, sounds like fading confidence. It isn’t. The lower target mostly reflects the dilution and a recent pullback in valuation multiples across AI chip stocks, not a change in the firm’s underlying growth thesis, the note said.

BofA still rates Intel a Buy and sees roughly 48% upside from current levels. The firm projects Intel could eventually capture 8% to 10% of a $380 billion global wafer foundry market by 2030, along with a quarter to a third of a fast-growing chip packaging market.

That combo could push Intel’s per-share earnings power above $6 by the end of the decade, according to the note.

Some of that opportunity already has names attached. BofA’s note points to early-stage discussions covering Apple’s M-series processor wafers and other prospective customers, as part of what could expand Intel’s addressable foundry market well beyond its current base.

None of those deals are finalized, but their presence in the analysis is part of why BofA views the capital raise as forward funding rather than a rescue.

Intel’s existing server chip business is already backing up that thesis. Server chip prices rose 43% year over year to roughly $1,200 per unit in the second quarter, BofA said, citing third-party market data.

BofA expects Intel’s foundry division to reach operating profitability by the end of 2027, barring a major shift in customer commitments.

Intel diluted shareholders with a $20 billion stock sale, but BofA says the raise funds a foundry bet worth $6 in per-share earnings by 2030.

Heather Diehl / Getty Images

Why I think this capital raise makes Intel a buy

Wall Street usually panics when they see share dilution, but when I look at this $20 billion capital raise, I do not see a red flag at all. I see a massive opportunity. Companies do not casually pull in over $100 billion in orders for a desperate rescue mission.

From what I can tell, Intel is using its recent momentum to build a massive war chest right when its core server business is finally regaining pricing power. Building world-class semiconductor foundries takes an incredible amount of cash, and I believe securing that capital now guarantees they will not have to slow their aggressive manufacturing timeline.

More Intel:

Intel, a legacy company in the business for more than 57 years, knows exactly what it takes to weather brutal cycles and reclaim its spot at the top of the tech food chain.

If you ask me, the risk-reward profile here looks exceptionally attractive for anyone willing to look past the short-term noise. Getting in around $95 lets you ride along on a multi-year structural turnaround, especially with rumors of major customer conversations with heavyweights like Apple starting to surface.

I really think that by the time Intel actually proves out its 14A process node and posts steady foundry profits, the biggest gains will already be gone. Accepting a modest 5% hit to immediate earnings per share feels like a very small tax to pay for a front-row seat to America’s most critical tech comeback.

Washington already ran this experiment

Washington ran this exact experiment a year ago, and it worked out better than almost anyone expected. The U.S. government converted roughly $8.9 billion in CHIPS Act grants and Secure Enclave funding into a 9.9% equity stake in Intel last August, buying in at $20.47 per share, according to CNBC.

That stake has since climbed toward $36 billion in value as Intel’s turnaround gained traction, according to a report by The Next Web.

That precedent doesn’t guarantee this week’s buyers see the same return, and Intel’s manufacturing turnaround remains unproven at scale.

Government ownership also complicates the picture, since Washington’s stake gives Intel political cover that ordinary shareholders don’t get to vote on. Still, it shows that betting equity on Intel’s foundry ambitions has already paid off once at a much lower entry price than this week’s $95.

The next signal to watch is yield data from Intel’s 18A and upcoming 14A manufacturing nodes, along with any confirmed external foundry customer beyond early discussions. Those two variables, more than the size of this week’s offering, will determine whether this second equity bet performs anything like the first one did for Washington.